Skip to content

Can Gaming Get You Fit? A High-Intensity Exergaming Intervention in Adults

Motivational High Intensity Training Through a Cutting-edge Gaming Platform. A Randomised, Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03513380
Enrollment
52
Registered
2018-05-01
Start date
2018-05-25
Completion date
2019-11-30
Last updated
2019-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary Lifestyle

Keywords

Exercise therapy, Physical fitness, Gaming, Adult, Healthy lifestyle, Fitness testing

Brief summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to health benefits. The project will include 50 adult participants that are not particularly physically active. They will be randomized into two groups where one group will be given free access to the exergame for 6 months. The physical fitness (maximal oxygen consumption), blood markers of cardiometabolic health and body composition of the subjects will be tested before, mid-ways and after the intervention period. Also, the participants gaming frequency will be registered throughout the 6-month period. Aim of this study is to investigate if access to this game can provide health benefits for individuals who are not motivated to take part in regular physical activity.

Interventions

BEHAVIORALExergaming

free access to the exergame PedalTanks during 6 months

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sedentary (\<150 mins of moderate intensity physical activity/week) * Able to ride a bike for up to 60 minutes

Exclusion criteria

* Known cardiovascular disease * Taking beta-blockers or anti-arrhythmic drugs

Design outcomes

Primary

MeasureTime frame
VO2max (Maximal Aerobic Capacity)3 months

Secondary

MeasureTime frameDescription
Daily average number of steps3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily average total physical activity duration3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Daily average energy expenditure3 and 6 monthsMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period, 3-months and 6-months.
Blood Pressure3 and 6 months
Fasting circulating glucose, as blood marker of cardiometabolic health6 months
Lipid profile, as blood marker of cardiometabolic health6 months
Circulating insulin concentration, as blood marker of cardiometabolic health6 months
glucose response to a 2 hour glucose tolerance test, as blood marker of cardiometabolic health6 months
Bioelectrical impedance3 and 6 monthsBody composition assessed using bioelectrical impedance analysis (InBody 720)

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026